153 related articles for article (PubMed ID: 17259641)
1. Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making.
Efficace F; Osoba D; Gotay C; Sprangers M; Coens C; Bottomley A
Ann Oncol; 2007 Apr; 18(4):775-81. PubMed ID: 17259641
[TBL] [Abstract][Full Text] [Related]
2. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?
Efficace F; Bottomley A; Osoba D; Gotay C; Flechtner H; D'haese S; Zurlo A
J Clin Oncol; 2003 Sep; 21(18):3502-11. PubMed ID: 12972527
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations.
Kvam AK; Fayers P; Hjermstad M; Gulbrandsen N; Wisloff F
Eur J Haematol; 2009 Oct; 83(4):279-89. PubMed ID: 19558508
[TBL] [Abstract][Full Text] [Related]
4. Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT-G).
Smith AB; Cocks K; Parry D; Taylor M
Qual Life Res; 2014 Apr; 23(3):971-6. PubMed ID: 24097080
[TBL] [Abstract][Full Text] [Related]
5. Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review.
Ter Veer E; van Kleef JJ; Sprangers MAG; Haj Mohammad N; van Oijen MGH; van Laarhoven HWM
Gastric Cancer; 2018 Mar; 21(2):183-195. PubMed ID: 29380191
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock.
Goodwin PJ; Black JT; Bordeleau LJ; Ganz PA
J Natl Cancer Inst; 2003 Feb; 95(4):263-81. PubMed ID: 12591983
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.
Claassens L; van Meerbeeck J; Coens C; Quinten C; Ghislain I; Sloan EK; Wang XS; Velikova G; Bottomley A
J Clin Oncol; 2011 May; 29(15):2104-20. PubMed ID: 21464420
[TBL] [Abstract][Full Text] [Related]
8. What is the methodological and reporting quality of health related quality of life in chronic heart failure clinical trials?
Chang S; Davidson PM; Newton PJ; Krum H; Salamonson Y; Macdonald P
Int J Cardiol; 2013 Apr; 164(2):133-40. PubMed ID: 22310219
[TBL] [Abstract][Full Text] [Related]
9. Is quality of life a suitable measure of patient decision aid effectiveness? Sub-analysis of a Cochrane systematic review.
Rutherford C; King MT; Butow P; Legare F; Lyddiatt A; Souli I; Rincones O; Stacey D
Qual Life Res; 2019 Mar; 28(3):593-607. PubMed ID: 30426276
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making.
Efficace F; Kemmler G; Vignetti M; Mandelli F; Molica S; Holzner B
Eur J Cancer; 2008 Jul; 44(11):1497-506. PubMed ID: 18555682
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in non-small-cell lung cancer: methodologic issues in randomized controlled trials.
Bottomley A; Efficace F; Thomas R; Vanvoorden V; Ahmedzai SH
J Clin Oncol; 2003 Aug; 21(15):2982-92. PubMed ID: 12885819
[TBL] [Abstract][Full Text] [Related]
12. Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials.
Efficace F; Bottomley A; Vanvoorden V; Blazeby JM
Eur J Cancer; 2004 Jan; 40(2):187-97. PubMed ID: 14728932
[TBL] [Abstract][Full Text] [Related]
13. Associations between safety, tolerability, and toxicity and the reporting of health-related quality of life in phase III randomized trials in common solid tumors.
Saleh RR; Meti N; Ribnikar D; Goldvaser H; Ocana A; Templeton AJ; Seruga B; Amir E
Cancer Med; 2020 Nov; 9(21):7888-7895. PubMed ID: 32886422
[TBL] [Abstract][Full Text] [Related]
14. Reporting on quality of life in randomised controlled trials in gastrointestinal surgery.
Bridoux V; Moutel G; Lefebure B; Scotte M; Michot F; Herve C; Tuech JJ
J Gastrointest Surg; 2010 Jan; 14(1):156-65. PubMed ID: 19826884
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality-of-life assessment in GI cancer randomized trials: improving the impact on clinical practice.
McNair AG; Blazeby JM
Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):559-67. PubMed ID: 19941433
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of the clinical evidence to guide treatment recommendations in breast reconstruction based on patient- reported outcome measures and health-related quality of life.
Winters ZE; Benson JR; Pusic AL
Ann Surg; 2010 Dec; 252(6):929-42. PubMed ID: 20729711
[TBL] [Abstract][Full Text] [Related]
17. Reporting of health-related quality of life endpoints in National Cancer Institute-supported cancer treatment trials.
St Germain D; Denicoff A; Torres A; Kelaghan J; McCaskill-Stevens W; Mishkin G; O'Mara A; Minasian LM
Cancer; 2020 Jun; 126(11):2687-2693. PubMed ID: 32237256
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of the quality of statistical methods employed for analysing quality of life data in cancer randomised controlled trials.
Hamel JF; Saulnier P; Pe M; Zikos E; Musoro J; Coens C; Bottomley A
Eur J Cancer; 2017 Sep; 83():166-176. PubMed ID: 28738257
[TBL] [Abstract][Full Text] [Related]
19. Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials.
Efficace F; Bottomley A; van Andel G
Cancer; 2003 Jan; 97(2):377-88. PubMed ID: 12518362
[TBL] [Abstract][Full Text] [Related]
20. Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours.
Martini C; Gamper EM; Wintner L; Nilica B; Sperner-Unterweger B; Holzner B; Virgolini I
Health Qual Life Outcomes; 2016 Sep; 14(1):127. PubMed ID: 27614762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
